Spectral Diagnostics Revenue 2010-2025 | EDTXF
Spectral Diagnostics revenue from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Spectral Diagnostics Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $2 |
| 2023 | $1 |
| 2022 | $1 |
| 2021 | $2 |
| 2020 | $2 |
| 2019 | $2 |
| 2018 | $3 |
| 2017 | $3 |
| 2016 | $3 |
| 2015 | $2 |
| 2014 | $3 |
| 2013 | $3 |
| 2012 | $3 |
| 2011 | $2 |
| 2010 | $3 |
| 2009 | $3 |
| Spectral Diagnostics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $1 |
| 2020-12-31 | $-372 |
| 2020-09-30 | $0 |
| 2020-06-30 | $373 |
| 2020-03-31 | $0 |
| 2019-12-31 | $1 |
| 2019-09-30 | $0 |
| 2019-06-30 | $1 |
| 2019-03-31 | $0 |
| 2018-12-31 | $1 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $1 |
| 2017-12-31 | $1 |
| 2017-09-30 | $1 |
| 2017-06-30 | $1 |
| 2017-03-31 | $1 |
| 2016-12-31 | $1 |
| 2016-09-30 | $1 |
| 2016-06-30 | $1 |
| 2016-03-31 | $1 |
| 2015-12-31 | $1 |
| 2015-09-30 | $1 |
| 2015-06-30 | $1 |
| 2015-03-31 | $1 |
| 2014-12-31 | $1 |
| 2014-09-30 | $1 |
| 2014-06-30 | $1 |
| 2014-03-31 | $1 |
| 2013-12-31 | $1 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $1 |
| 2012-12-31 | $1 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $1 |
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| 2011-03-31 | $1 |
| 2010-12-31 | $1 |
| 2010-09-30 | $1 |
| 2010-06-30 | $1 |
| 2010-03-31 | $1 |
| 2009-12-31 | $1 |
| 2009-09-30 | $1 |
| 2009-06-30 | $1 |
| 2009-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.177B | $0.002B |
| Spectral Medical Inc. develops and commercializes theranostic treatment for severe sepsis. The company's products include Endotoxin Activity Assay, a rapid diagnostic test for detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device for the treatment of sepsis that removes endotoxin from the bloodstream. Spectral Medical Inc., formerly known as Spectral Diagnostics Inc., is headquartered in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $188.546B | 82.58 |
| Thermo Fisher Scientific (TMO) | United States | $162.598B | 19.67 |
| Edwards Lifesciences (EW) | United States | $46.224B | 30.31 |
| Alcon (ALC) | Switzerland | $43.751B | 29.57 |
| IDEXX Laboratories (IDXX) | United States | $43.516B | 50.01 |
| DexCom (DXCM) | United States | $33.510B | 51.79 |
| IQVIA Holdings (IQV) | United States | $28.637B | 16.04 |
| Mettler-Toledo (MTD) | United States | $25.693B | 30.56 |
| STERIS (STE) | Ireland | $22.696B | 25.00 |
| Waters (WAT) | United States | $21.023B | 29.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.706B | 0.00 |
| Hologic (HOLX) | United States | $14.897B | 16.19 |
| Sysmex ADR (SSMXY) | Japan | $10.505B | 29.80 |
| Penumbra (PEN) | United States | $9.444B | 74.12 |
| Masimo (MASI) | United States | $9.018B | 33.26 |
| Globus Medical (GMED) | United States | $7.825B | 18.65 |
| Glaukos (GKOS) | United States | $6.088B | 0.00 |
| Teleflex (TFX) | United States | $5.300B | 8.75 |
| Integer Holdings (ITGR) | United States | $4.249B | 22.26 |
| TransMedics (TMDX) | United States | $4.221B | 91.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.276B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.545B | 15.15 |
| Veracyte (VCYT) | United States | $2.155B | 30.24 |
| Nihon Kohden (NHNKY) | Japan | $2.134B | 24.47 |
| Elekta AB (EKTAY) | Sweden | $1.961B | 17.63 |
| Alphatec Holdings (ATEC) | United States | $1.693B | 0.00 |
| Artivion (AORT) | United States | $1.390B | 130.24 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.077B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.023B | 5.44 |
| SiBone (SIBN) | United States | $0.800B | 0.00 |
| IRadimed (IRMD) | United States | $0.756B | 38.37 |
| Semler Scientific (SMLR) | United States | $0.629B | 13.64 |
| Beta Bionics (BBNX) | United States | $0.588B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.567B | 8.82 |
| AxoGen (AXGN) | United States | $0.549B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.545B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.493B | 11.55 |
| Pacific Biosciences Of California (PACB) | United States | $0.450B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.445B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.437B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.391B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.344B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.335B | 0.00 |
| NeuroPace (NPCE) | United States | $0.334B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.267B | 0.00 |
| 908 Devices (MASS) | United States | $0.259B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.239B | 14.45 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Inogen (INGN) | United States | $0.197B | 0.00 |
| CVRx (CVRX) | United States | $0.181B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| Accuray (ARAY) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.128B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.120B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.096B | 0.00 |
| Spectral AI (MDAI) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.075B | 45.80 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.22 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.023B | 0.00 | |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.69 |